FAQ

SR 4554

Known as: SR-4554 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1995-2008
01219952008

Related topics

Related topics

1 relation

Broader (1)

Nitroimidazoles

Related mentions per year

Related mentions per year

1960-2018
1960198020002020
SR 4554
Nitroimidazoles

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
In vivo detection of the metabolism of novel hypoxia probes in models of glioma by H NMR
Introduction: Hypoxia is known to play a central role in many oncologic processes providing the common link among tumor… (More)
Is this relevant?
2008
2008
2-Nitroimidazole as Potential Nanoprobe in Hypoxia Imaging by MRI/PET
2-Nitroimidazole is radiosensitizer and serves as imaging contrast agent by 19Fand 31P MR methods. Despite the success of… (More)
  • table 1
  • figure 3
  • figure 1
  • figure 2
  • figure 4
Is this relevant?
Review
2003
Review
2003
A phase I study of SR-4554 via intravenous administration for noninvasive investigation of tumor hypoxia by magnetic resonance spectroscopy in patients with malignancy.
PURPOSE To perform a Phase I study of SR-4554, a fluorinated 2-nitroimidazole noninvasive probe of tumor hypoxia detected by (19… (More)
  • figure 1
  • figure 2
  • table 2
  • figure 3
  • table 3
Is this relevant?
Review
2003
Review
2003
The role of functional and molecular imaging in cancer drug discovery and development.
Studies of pharmacokinetics (which is what the body does to the drug) and pharmacodynamics (which is what the drug does to the… (More)
Is this relevant?
2002
2002
Validation of the fluorinated 2-nitroimidazole SR-4554 as a noninvasive hypoxia marker detected by magnetic resonance spectroscopy.
PURPOSE Tumor hypoxia is associated with poor prognosis and a more malignant tumor phenotype. SR-4554, a fluorinated 2… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 5
Is this relevant?
1998
1998
The relationship between tumour oxygenation determined by oxygen electrode measurements and magnetic resonance spectroscopy of the fluorinated 2-nitroimidazole SR-4554.
The relationship between two methods of assessing tumour oxygenation in vivo, namely oxygen electrode measurement and magnetic… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
Is this relevant?
1997
1997
Preclinical evaluation of the fluorinated 2-nitroimidazole N-(2-hydroxy-3,3,3-trifluoropropyl)-2-(2-nitro-1-imidazolyl) acetamide (SR-4554) as a probe for the measurement of tumor hypoxia.
A novel probe, N-(2-hydroxy-3,3,3,-trifluoropropyl)-2-(2-nitro-1-imidazolyl) acetamide (SR-4554), has been used to detect tumor… (More)
Is this relevant?
1997
1997
Bioreductive metabolism of the novel fluorinated 2-nitroimidazole hypoxia probe N-(2-hydroxy-3,3,3-trifluoropropyl)-2-(2-nitroimidazolyl) acetamide (SR-4554).
The aim of this work was to study the metabolic characteristics of the novel fluorinated 2-nitroimidazole hypoxia probe N-(2… (More)
Is this relevant?
1996
1996
The pharmacokinetics, bioavailability and biodistribution in mice of a rationally designed 2-nitroimidazole hypoxia probe SR-4554.
N-(2-Hydroxy-3,3,3-trifluoropropyl)-2-(2-nitro-1-imidazolyl) acetamide (SR-4554) is a fluorinated 2-nitroimidazole which has been… (More)
Is this relevant?
1995
1995
The novel fluorinated 2-nitroimidazole hypoxia probe SR-4554: reductive metabolism and semiquantitative localisation in human ovarian cancer multicellular spheroids as measured by electron energy…
The novel fluorinated 2-nitroimidazole SR-4554 is undergoing preclinical development as a magnetic resonance spectroscopy and… (More)
  • figure 1
  • figure 2
  • table I
  • figure 3
  • figure 4
Is this relevant?